| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±4.9% | -3.4% | over-priced |
| 04/30/2026 | ±3.2% | +3.0% | over-priced |
| 02/04/2026 | ±2.7% | +1.9% | over-priced |
| 10/30/2025 | ±2.3% | -18.2% | under-priced |
| 07/24/2025 | ±2.4% | -13.3% | under-priced |
| 04/24/2025 | ±3.7% | +1.6% | over-priced |
| 02/05/2025 | ±2.2% | -2.6% | under-priced |
| 10/30/2024 | ±1.8% | -7.9% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.32 | $3.3B | $404M |
| Q1 FY2026 | $0.23 | $3.1B | $303M |
| Q4 FY2025 | — | $3.0B | $331M |
| Q3 FY2025 | $0.29 | $3.0B | $382M |
CMG (CMG) reports in 6 days, with the next report estimated for 11/02/2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 6.5% on average — the market has been roughly fair on CMG's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 9.3%. QuantLogix's live 5-factor engine currently reads CMG as a neutral at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →